<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:pp="http://www.presspage.com/rss/"
     version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom">
                <channel>
                    <title><![CDATA[Cedars-Sinai Newsroom | Health Breakthroughs & Expert News]]></title>
                    <link>https://www.cedars-sinai.org/newsroom/</link>
                    <description></description>
                    <language>en-us</language>
                    <lastBuildDate>Tue, 17 Nov 2026 07:58:13 +0100</lastBuildDate>
                    <pubDate>Wed, 11 Nov 2026 15:38:26 +0000</pubDate>
                    <image>
                        <title><![CDATA[Cedars-Sinai Newsroom | Health Breakthroughs & Expert News]]></title>
                        <url>https://content.presspage.com/clients/150_2110.png</url>
                        <link>https://www.cedars-sinai.org/newsroom/</link>
                        <width>144</width>
                    </image><item>
                        <title>How Cedars-Sinai Is Using Whole-Genome Sequencing to Care for Children</title>
                        <link>https://www.cedars-sinai.org/newsroom/how-cedars-sinai-is-using-whole-genome-sequencing-to-care-for-children/</link>
                        <guid>https://www.cedars-sinai.org/newsroom/how-cedars-sinai-is-using-whole-genome-sequencing-to-care-for-children/</guid><pp:caseid>822956</pp:caseid><pp:subtitle>Advanced Genetic Testing May Help Clinicians Personalize Care for Complex Pediatric Conditions Like Cerebral Palsy and Childhood Cancer</pp:subtitle><description><![CDATA[<p><span>Two studies involving investigators at </span><a href="https://www.cedars-sinai.edu/health-sciences-university/research/departments-institutes/guerin-childrens.html"><span>Cedars-Sinai Guerin Children’s</span></a><span> and the </span><a href="https://www.cam.ac.uk/" target="_blank" rel="noreferrer noopener"><span>University of Cambridge</span></a><span>, U.K., highlight the growing potential of whole-genome sequencing to transform the diagnosis and treatment of childhood conditions such as cerebral palsy and cancer.</span></p><p><span>Whole-genome sequencing is an analysis of the roughly 20,000 genes in a person’s DNA. The test, usually performed using a blood or saliva sample, is used to identify genetic variations that may be linked to various diseases.<img class="image-style-align-right image_resized" style="width:225px;" src="https://content.presspage.com/uploads/2110/c51a731d-a7b6-4932-b592-245ccd07b84b/800_rowitch-david.rowitchd.jpg?x=1793314180353" width="225" alt="David H. Rowitch, MD, PhD" /></span></p><p><span>The first study, published in </span><a href="https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(26)00198-5/fulltext" target="_blank" rel="noreferrer noopener"><i><span>The Lancet Regional Health–Europe</span></i></a><span>, investigated the use of whole-genome sequencing to identify genetic causes of cerebral palsy in children.</span></p><p><span>The second study, published in </span><a href="https://www.nature.com/articles/s41467-026-77918-x" target="_blank" rel="noreferrer noopener"><i><span>Nature Communications</span></i></a><span>, examined whether rapid whole-genome sequencing—with results available in three to seven days, compared with several weeks for standard testing—could improve the diagnosis and treatment of children with cancer.</span></p><p><span>“Whole-genome sequencing gives us an opportunity to better understand why a child develops a particular condition and, in some cases, to change how we care for that child,” said </span><a href="https://researchers.cedars-sinai.edu/David.Rowitch"><span>David Rowitch, MD, PhD</span></a><span>, deputy director of Research at Cedars-Sinai Guerin Children’s, professor of Paediatrics at the University of Cambridge and corresponding author of both studies.</span></p><p><span>The term for this type of care is “genomic medicine.” The </span><i><span>Cedars-Sinai Newsroom</span></i><span> spoke with Rowitch to discuss the studies’ implications for children and families and how Cedars-Sinai Guerin Children’s is working to expand access to genomic medicine in Los Angeles and beyond.</span></p><h2><span><strong>Whole-Genome Sequencing and Cerebral Palsy</strong></span></h2><h3><span><strong>What is cerebral palsy and how is it diagnosed?</strong></span></h3><p><span>Cerebral palsy is a lifelong condition caused by damage to the developing brain from premature birth, infections or brain injuries. Globally, 18 million people have cerebral palsy, and the condition can affect movement, muscle control, learning and communication skills. It’s typically diagnosed by a pediatrician or neurologist through physical and neurological tests and brain imaging.</span></p><h3><span><strong>Can cerebral palsy have a genetic cause, and how common might that be?</strong></span></h3><p><span>Recent evidence indicates that about 1 in 4 people with cerebral palsy may have an underlying DNA mutation in a specific gene. Genetics has increasingly become an important consideration when evaluating cerebral palsy, and research shows that more than 100 genes are linked to the condition.</span></p><p><span>Whole-genome sequencing, usually involving the child and both parents, can diagnose genetic conditions and help determine whether a variant was inherited or occurs in the child only.</span></p><h3><span><strong>When should a child with cerebral palsy have whole-genome sequencing?</strong></span></h3><p><span>The appropriate criteria for genetic testing in children with cerebral palsy are not yet well established. More guidelines are needed to help decide when to test. If a genetic cause is suspected, such as no known risk factors, testing children early may help guide treatment and care.</span></p><h3><span><strong>How does finding an underlying genetic cause change cerebral palsy treatment?</strong></span></h3><p><span>A genetic diagnosis can lead to precision medicine treatments and help physicians identify other health risks that should be monitored. For example, if we found that cerebral palsy is part of a genetic syndrome that has a cardiac component, we would refer that patient for cardiology consultation and assessment. In our study, we changed care plans for about 63% of children who received a genetic diagnosis.</span></p><h3><span><strong>How is whole-genome sequencing improving cerebral palsy care at Guerin Children’s?</strong></span></h3><p><span>Identifying the specific genes involved in the disease creates opportunities for new research that may lead to new treatments, such as gene therapy.</span></p><p><span>At Cedars-Sinai Guerin Children’s, we are researching a gene called CTNNB1, which is commonly found in patients with cerebral palsy. This research aims to help us understand what goes wrong in the nervous systems of children with this gene mutation. We recently launched a whole-genome sequencing protocol for use in neonatal and pediatric intensive care units to expand our research and its benefits to patients.</span></p><h2><span><strong>Rapid Whole-Genome Sequencing and Childhood Cancer</strong></span></h2><h3><span><strong>How can rapid whole-genome sequencing change a child’s cancer care?</strong></span></h3><p><span>Previous studies from the University of Cambridge showed that whole-genome sequencing was more effective than standard genetic tests for diagnosing childhood cancer, but results took three to six weeks.</span></p><p><span>Faster results can help clinicians provide a more precise diagnosis, make treatment decisions earlier, avoid unnecessary interventions or treatments, and adjust chemotherapy dose. In our study of 54 children with cancer, we concluded that about 50% of the cases benefited from having a more rapid return of results. For some children, we adjusted their chemotherapy dose to fit their metabolism; for others, we switched medications. In one dramatic case, we withheld treatment.</span></p><h3><span><strong>What are the next steps for bringing rapid whole-genome sequencing into routine pediatric cancer care?</strong></span></h3><p><span>Our study, although it was small and involved a limited patient population, showed clear benefits. National adoption of rapid whole-genome sequencing is being tested in the U.K. In the U.S., this will require institutions to champion this diagnostic approach and increase access and capacity.</span></p><p><span>At Cedars-Sinai Guerin Children’s, an important next step is to explore how these capabilities can be extended more broadly to pediatric oncology and other specialties where genomic information can make a difference. The goal is not simply to provide a diagnosis, but to help clinicians choose the right care for each child.</span></p><p><span style="color:hsl(353,76%,49%);"><i><span><strong>Read more from Cedars-Sinai Stories and Insights: </strong></span></i></span><a href="https://www.cedars-sinai.org/stories-and-insights/innovation-and-research/personalizing-disease-prevention-from-birth"><span style="color:hsl(353,76%,49%);"><i><span><strong>Personalizing Disease Prevention From Birth</strong></span></i></span></a></p>]]></description><category><![CDATA[Research,Exclude,cedars-sinai guerin children&#039;s,Guerin Childrens,Shishira Sreenivas,david-rowitch-884968,cerebral palsy,pediatric cancer,genomic medicine]]></category>
            <pubDate>Fri, 30 Oct 2026 06:00:00 -0700</pubDate>
            <pp:lastModified>Wed, 11 Nov 2026 15:38:26 +0000</pp:lastModified>
            <enclosure url="https://content.presspage.com/uploads/2110/d43540aa-4a10-4006-901b-9cea7b7bed9a/500_dna-test-breast-cancer-cedars-sinai.jpg?10000" length="0" type="image/jpg" />
                <pp:image>https://content.presspage.com/uploads/2110/d43540aa-4a10-4006-901b-9cea7b7bed9a/500_dna-test-breast-cancer-cedars-sinai.jpg?10000</pp:image>
                <pp:imageOriginal>https://content.presspage.com/uploads/2110/d43540aa-4a10-4006-901b-9cea7b7bed9a/dna-test-breast-cancer-cedars-sinai.jpg?10000</pp:imageOriginal><pp:imageTitle><![CDATA[David Rowitch, MD, PhD, deputy director of Research at Cedars-Sinai Guerin Children&amp;rsquo;s, discusses how whole genome sequencing can help improve diagnosis and care for children with complex pediatric conditions. Photo by Getty.]]></pp:imageTitle><pp:imageDescription><![CDATA[Lab expert examining dna sequence.]]></pp:imageDescription></item><item>
                        <title>How Robotic Surgery Helped Tackle a Rare Pediatric Lung Tumor</title>
                        <link>https://www.cedars-sinai.org/newsroom/how-robotic-surgery-helped-tackle-a-rare-pediatric-lung-tumor/</link>
                        <guid>https://www.cedars-sinai.org/newsroom/how-robotic-surgery-helped-tackle-a-rare-pediatric-lung-tumor/</guid><pp:caseid>817653</pp:caseid><pp:subtitle>Cedars-Sinai Guerin Children’s Team Uses Minimally Invasive Technique to Treat 12-Year-Old With Exceptionally Rare Cancer</pp:subtitle><description><![CDATA[<p><span>When 12-year-old Angela Beltran developed a persistent cough that left her struggling to breathe, her mother knew something was seriously wrong.  </span></p><p><span>“The last cough she had scared me. She woke up and she couldn’t breathe,” said Anita Sanchez, Angela’s mother.</span></p><p><span>Sanchez rushed Angela to a physician in her hometown of Sinaloa, Mexico. After initial scans were inconclusive, she brought Angela to Los Angeles for further testing. When a CT scan revealed a small white patch on her left lung, Angela was referred to </span><a href="https://researchers.cedars-sinai.edu/Leo.Mascarenhas"><span>Leo Mascarenhas, MD</span></a><span>, director of </span><a href="https://www.cedars-sinai.org/programs/pediatrics/specialties/hematology-oncology.html"><span>Pediatric Hematology and Oncology</span></a><span> at </span><a href="https://www.cedars-sinai.org/programs/pediatrics.html"><span>Cedars-Sinai Guerin Children’s</span></a><span>.</span></p><p><span>When Mascarenhas took a close look at Angela’s scans, he suspected it to be an exceptionally rare lung tumor.<img class="image_resized image-style-align-right" style="width:273px;" src="https://content.presspage.com/uploads/2110/83759791-a5b3-487f-8f7c-7a41ae394374/800_leo-mascarenhas-md-ms-cedars-sinai.jpg?x=1790788089620" alt="Leo Mascarenhas, MD" width="273" /></span></p><p><span>“I examined her scans and noticed the tumor was arising out of one of the branches of the windpipe called a bronchus. It looked like bronchopulmonary mucoepidermoid carcinoma,” he said. “It’s really seen in adults. But I’ve taken care of a few cases over the years, and it can occur in children even though it’s very, very rare.”</span></p><p><span>Bronchopulmonary mucoepidermoid carcinoma is an ultra-rare form of lung cancer that arises in the mucus-producing glands of the airways and is typically seen in adults. In children, it is exceedingly rare, accounting for fewer than 0.2 cases per million pediatric tumors.</span></p><p><span>The next day, </span><a href="https://researchers.cedars-sinai.edu/Andrew.Brownlee"><span>Andrew Brownlee, MD</span></a><span>, an adult thoracic surgeon who primarily cares for adults at the Jim and Eleanor Randall Department of Surgery at Cedars-Sinai, collaborated with </span><a href="https://researchers.cedars-sinai.edu/Eugene.KimX"><span>Eugene Kim, MD</span></a><span>, surgeon-in-chief at Guerin Children’s, to perform a robotic bronchoscopy.</span></p><p><span>This minimally invasive technology allows physicians to biopsy tumors and examine nearby lymph nodes through the airway without opening the chest.<img class="image_resized image-style-align-right" style="width:200px;" src="https://content.presspage.com/uploads/2110/e1f069a3-27b3-4ef6-93e1-b1eb35dd55e9/500_andrewbrownleemd.jpg?x=1790780793917" alt="Andrew Brownlee, MD" width="200" /></span></p><p><span>The biopsy confirmed Mascarenhas’ suspicions. Angela had a 3-centimeter tumor lodged by the branch of the windpipe in her left lung. Fortunately, the cancer hadn’t spread elsewhere in the body. Surgery was the only option to remove the tumor. </span></p><p><span>“As a mother, I think I could feel something was wrong, but I never imagined it would be this bad,” Sanchez said. “But Dr. Brownlee was confident he could take out the tumor, so I was grateful she was in good hands.”</span></p><p><span>Traditional open-chest surgery can mean a longer recovery, time away from school and potential chest wall deformities as children grow. Brownlee instead suggested a minimally invasive robot-assisted surgery. Angela was just above the weight threshold needed for the procedure.</span></p><p><span>“One of the unique things that we can offer here at Cedars-Sinai is that this is a children's hospital within an adult medical center,” Brownlee said. “We perform robotic thoracic surgery in adults multiple times per week. That experience allows us to bring this highly specialized expertise to a child when appropriate.”<img class="image_resized image-style-align-right" style="width:264px;" src="https://content.presspage.com/uploads/2110/ef0a05b8-f176-4af2-bf6b-bef632269ab1/800_7b4b6e90-b0f8-4b5b-95d3-61ef1962c282.jpg?x=1790783233514" alt="Angela Beltran with her mother, Anita Sanchez. Photo courtesy of Anita Sanchez." width="264" />  </span></p><p><span>The surgery was successful. Within a week after receiving the devastating diagnosis, Angela had the tumor removed along with the lower left lobe of her lung. Just two days later, she was discharged from the hospital. </span></p><p><span>Two years later, Angela, now 14, remains cancer-free. She returns to Los Angeles every six months for follow-up visits with Mascarenhas. Back home in Sinaloa, she’s busy being a teenager, spending time with her siblings and navigating high school.</span></p><p><span>“When I was first told I had lung cancer, I felt nervous and scared. But since everything is fine now, I feel much better. I feel like everything is still going to be OK,” Angela said.</span></p><p><span>Mascarenhas credits Angela’s outcome to the multidisciplinary team he was able to quickly assemble to care for her—an approach Kim says sets Guerin Children’s apart.</span></p><p><span>“We’ve been building a collaboration among pediatric surgery, oncology and thoracic surgery for many years now,” Kim said. “The goal has always been to bring together the best aspects of each division to offer something truly unique to our patients. Much of that expertise involves minimally invasive techniques that may not be readily available at dedicated children’s hospitals.”</span></p><p><span>Sanchez is grateful she brought her daughter to Los Angeles for care.</span></p><p><span>“I think that she couldn’t have had this type of care anywhere else,” Sanchez said. “We had the best doctors and nurses. They’re the people who saved my daughter’s life. And I’m always going to be thankful for that.” </span></p><p><span style="color:hsl(353,76%,49%);"><i><span><strong>Read more from Cedars-Sinai Stories and Insights: </strong></span></i></span><a href="https://www.cedars-sinai.org/stories-and-insights/innovation-and-research/the-unscreenable-cancers"><span style="color:hsl(353,76%,49%);"><i><span><strong>The "Unscreenable" Cancers</strong></span></i></span></a></p>]]></description><category><![CDATA[News,cedars-sinai guerin children&#039;s,pediatric cancer,Lung Cancer,Surgery,leo-mascarenhas-477579,andrew-brownlee-2452710,Shishira Sreenivas]]></category>
            <pubDate>Thu, 01 Oct 2026 07:19:58 -0700</pubDate>
            <pp:lastModified>Thu, 01 Oct 2026 16:19:58 +0000</pp:lastModified>
            <enclosure url="https://content.presspage.com/uploads/2110/2e12526e-0137-4825-9108-903286abbbc2/500_angelabeltranlandscape.jpg?10000" length="0" type="image/jpg" />
                <pp:image>https://content.presspage.com/uploads/2110/2e12526e-0137-4825-9108-903286abbbc2/500_angelabeltranlandscape.jpg?10000</pp:image>
                <pp:imageOriginal>https://content.presspage.com/uploads/2110/2e12526e-0137-4825-9108-903286abbbc2/angelabeltranlandscape.jpg?10000</pp:imageOriginal><pp:imageTitle><![CDATA[After undergoing minimally invasive robotic surgery at Cedars-Sinai Guerin Children&amp;rsquo;s to remove a rare pediatric lung tumor, Angela Beltran remains cancer-free. Photo by Anita Sanchez.]]></pp:imageTitle><pp:imageDescription><![CDATA[12-year-old Angela Beltran at Cedars-Sinai after lung tumor surgery.]]></pp:imageDescription></item></channel>
                    </rss>